Table of Contents
List of Tables
List of Figures
1 Introduction
1.1 What Is This Report About?
1.2 Surgical Heart Valves Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Surgical Heart Valves Market, EU5
2.1 Surgical Heart Valves Market, EU5, Revenue ($m), 2024-2036
2.2 Surgical Heart Valves Market, EU5, Revenue ($m), 2024-2036
2.3 Surgical Heart Valves Market, EU5, Volume (Units), 2024-2036
2.4 Surgical Heart Valves Market, EU5, Volume (Units), 2024-2036
2.5 Surgical Heart Valves Market, EU5, Company Share by Revenue ($m), 2025
3 Surgical Heart Valves Market, France
3.1 Surgical Heart Valves Market, France, Revenue ($m), 2024-2036
3.1.1 Cardiac Valve Repair Devices Market, France, Revenue ($m), by Segment, 2024-2036
3.1.2 Prosthetic Heart Valves Market, France, Revenue ($m), by Segment, 2024-2036
3.2 Surgical Heart Valves Market, France, Volume (Units), 2024-2036
3.2.1 Cardiac Valve Repair Devices Market, France, Volume (Units), by Segment, 2024-2036
3.2.2 Prosthetic Heart Valves Market, France, Volume (Units), by Segment, 2024-2036
3.3 Surgical Heart Valves Market, France, Average Price ($), 2024-2036
3.4 Surgical Heart Valves Market, France, Company Share by Revenue ($m), 2025
4 Surgical Heart Valves Market, Germany
4.1 Surgical Heart Valves Market, Germany, Revenue ($m), 2024-2036
4.1.1 Cardiac Valve Repair Devices Market, Germany, Revenue ($m), by Segment, 2024-2036
4.1.2 Prosthetic Heart Valves Market, Germany, Revenue ($m), by Segment, 2024-2036
4.2 Surgical Heart Valves Market, Germany, Volume (Units), 2024-2036
4.2.1 Cardiac Valve Repair Devices Market, Germany, Volume (Units), by Segment, 2024-2036
4.2.2 Prosthetic Heart Valves Market, Germany, Volume (Units), by Segment, 2024-2036
4.3 Surgical Heart Valves Market, Germany, Average Price ($), 2024-2036
4.4 Surgical Heart Valves Market, Germany, Company Share by Revenue ($m), 2025
5 Surgical Heart Valves Market, Italy
5.1 Surgical Heart Valves Market, Italy, Revenue ($m), 2024-2036
5.1.1 Cardiac Valve Repair Devices Market, Italy, Revenue ($m), by Segment, 2024-2036
5.1.2 Prosthetic Heart Valves Market, Italy, Revenue ($m), by Segment, 2024-2036
5.2 Surgical Heart Valves Market, Italy, Volume (Units), 2024-2036
5.2.1 Cardiac Valve Repair Devices Market, Italy, Volume (Units), by Segment, 2024-2036
5.2.2 Prosthetic Heart Valves Market, Italy, Volume (Units), by Segment, 2024-2036
5.3 Surgical Heart Valves Market, Italy, Average Price ($), 2024-2036
5.4 Surgical Heart Valves Market, Italy, Company Share by Revenue ($m), 2025
6 Surgical Heart Valves Market, Spain
6.1 Surgical Heart Valves Market, Spain, Revenue ($m), 2024-2036
6.1.1 Cardiac Valve Repair Devices Market, Spain, Revenue ($m), by Segment, 2024-2036
6.1.2 Prosthetic Heart Valves Market, Spain, Revenue ($m), by Segment, 2024-2036
6.2 Surgical Heart Valves Market, Spain, Volume (Units), 2024-2036
6.2.1 Cardiac Valve Repair Devices Market, Spain, Volume (Units), by Segment, 2024-2036
6.2.2 Prosthetic Heart Valves Market, Spain, Volume (Units), by Segment, 2024-2036
6.3 Surgical Heart Valves Market, Spain, Average Price ($), 2024-2036
6.4 Surgical Heart Valves Market, Spain, Company Share by Revenue ($m), 2025
7 Surgical Heart Valves Market, United Kingdom
7.1 Surgical Heart Valves Market, United Kingdom, Revenue ($m), 2024-2036
7.1.1 Cardiac Valve Repair Devices Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.1.2 Prosthetic Heart Valves Market, United Kingdom, Revenue ($m), by Segment, 2024-2036
7.2 Surgical Heart Valves Market, United Kingdom, Volume (Units), 2024-2036
7.2.1 Cardiac Valve Repair Devices Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.2.2 Prosthetic Heart Valves Market, United Kingdom, Volume (Units), by Segment, 2024-2036
7.3 Surgical Heart Valves Market, United Kingdom, Average Price ($), 2024-2036
7.4 Surgical Heart Valves Market, United Kingdom, Company Share by Revenue ($m), 2025
8 Surgical Heart Valves Market Pipeline Products
8.1 Surgical Heart Valves Market Pipeline Products
8.2 Surgical Heart Valves – Pipeline Products by Stage of Development
8.3 Surgical Heart Valves – Pipeline Products by Segment
8.4 Surgical Heart Valves – Pipeline Products by Territory
8.5 Surgical Heart Valves – Pipeline Products by Regulatory Path
8.6 Surgical Heart Valves – Pipeline Products by Estimated Approval Date
9 Overview of Key Companies in EU5 Surgical Heart Valves Market
9.1 Edwards Lifesciences Corp
9.1.1 Company Overview
9.2 Abbott Laboratories
9.2.1 Company Overview
9.3 Medtronic Plc
9.3.1 Company Overview
9.4 Artivion Inc
9.4.1 Company Overview
9.5 Corcym UK Ltd
9.5.1 Company Overview
10 Recent Developments
10.1 Corporate Communications
10.1.1 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.1.2 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem
10.1.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.1.4 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
10.2 Financial Announcements
10.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
10.3 Government and Public Interest
10.3.1 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
10.4 Other Significant Developments
10.4.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
10.4.2 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.4.3 Oct 17, 2025: New Value Based Procurement Guidelines Launched
10.4.4 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
10.5 Product News
10.5.1 Nov 20, 2025: Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Clinical Results
10.5.2 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
10.5.3 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
10.5.4 Nov 07, 2025: Gore Announces Positive Clinical Trial Results of the Investigational Gore Viabahn Fortegra Venous Stent for Treatment of Patients with Deep Venous Iliocaval Obstruction
10.5.5 Nov 05, 2025: Fluid Control Solutions For MedTech
10.5.6 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
10.5.7 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
10.5.8 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter
10.5.9 Oct 07, 2025: Enea Tech and Biomedical Collaborate with Innovheart on Saturn TMVR System Development
10.5.10 Sep 28, 2025: Acoramidis Reduces Cardiovascular Outcomes in ATTR-CM Patients Within the First Month
10.6 Strategy And Business Planning
10.6.1 Nov 20, 2025: New Propelus Prototype Centers
10.6.2 Nov 13, 2025: Angelini Ventures Opens First Asia Office to Enhance Singapore Biotech Ecosystem
10.6.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
10.6.4 Oct 07, 2025: Enea Tech and Biomedical Collaborate with Innovheart on Saturn TMVR System Development
11 Appendix
11.1 Research Methodology
11.1.1 Coverage
11.1.2 Secondary Research
11.1.3 Primary Research
11.1.4 Market Modeling and Forecasting
11.1.5 Company Share Analysis
11.1.6 Benchmarking
11.2 GlobalData Consulting
11.3 Contact Us
11.4 Disclaimer